The expression of BCL11A is significantly increased in patients with malignant B lymphoblastoma, providing a possible explanation for the resistance to apoptosis in patients with chronic lymphocytic leukemia [7,24]. This evidence concerns the gene BCL11A and B-cell chronic lymphocytic leukemia.